Is Nemolizumab expensive? Prices and purchase methods of medicines by region

Nemolizumab (trade name: Nemluvio) is an innovative biologic agent used to treat chronic nodular pruritus and moderate to severe atopic dermatitis. Due to its high R&D costs and production process, the drug sells for a relatively high price. The following is an overview of nemolizumab's selling prices in different regions and how to purchase it.

In the United States, the retail price of nemolizumab is approximately $4,536 per 30 mg injection. Depending on the patient's weight and condition, treatment options may require injections once or twice a month. As a result, annual treatment costs can run into tens of thousands of dollars. However, patients can get discounts through platforms like GoodRx and the price can drop to about $4,184 per vial. In addition, patient assistance programs offered by manufacturers and nonprofit organizations may also help reduce costs for eligible patients.

In Europe, nemolizumab pricing varies by country. For example, in the UK, NICE (the National Institute for Health and Clinical Excellence) recommends a retail price of around £2,257 for a 30 mg vial. However, the actual price paid may vary due to commercial arrangements and discounts. Patients can get the medicine through the National Health Service (NHS) or private health insurance.

In Japan, nemolizumab will be launched by Chugai Pharmaceuticals in 2022 under the trade name Mitchga®. Specific selling prices may vary depending on health insurance and hospital pricing policies. Patients can obtain the drug through Japan's health insurance system or private medical institutions.

In other countries and regions, the availability and selling price of nemolizumab may not yet be determined. Patients should check with their local medical provider or drug supplier to learn about the availability and price of this drug.

In summary, the price of nemolizumab is higher, but patients can reduce the cost in many ways. It is recommended that patients choose an appropriate treatment plan under the guidance of a doctor and based on their own financial situation.

Reference materials:https://www.drugs.com/